Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 30, 2017

DrugPatentWatch Database Preview

Diethylpropion hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diethylpropion hydrochloride and what is the scope of diethylpropion hydrochloride patent protection?

Diethylpropion hydrochloride
is the generic ingredient in five branded drugs marketed by Avanthi Inc, Sandoz, Actavis Labs Ut Inc, Corepharma, Watson Labs, Teva, Ucb Inc, 3M, Tg United Labs, Sanofi Aventis Us, and Lannett Holdings Inc, and is included in sixteen NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for diethylpropion hydrochloride. Seventeen suppliers are listed for this compound.

Summary for Generic Name: diethylpropion hydrochloride

Drug Master File Entries: see list11
Suppliers / Packagers: see list17
Bulk Api Vendors: see list36
Clinical Trials: see list988
Patent Applications: see list7,319
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diethylpropion hydrochloride at DailyMed

Pharmacology for Ingredient: diethylpropion hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Ut Inc
diethylpropion hydrochloride
TABLET, EXTENDED RELEASE;ORAL012546-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe
diethylpropion hydrochloride
TABLET;ORAL088642-001Sep 20, 1984DISCNNoNo► Subscribe► Subscribe
diethylpropion hydrochloride
TABLET;ORAL040828-001Nov 5, 2008DISCNNoNo► Subscribe► Subscribe
diethylpropion hydrochloride
TABLET;ORAL011673-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Tg United Labs
diethylpropion hydrochloride
TABLET;ORAL088267-001Aug 25, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus